Objective-In people without previous stroke, covert findings on serial magnetic resonance imaging (MRI) of incident brain infarcts and worsening leukoaraiosis are associated with increased risk for ischemic stroke and dementia. We evaluated whether various measures of blood pressure (BP) and heart rate are associated with these MRI findings. Approach and Results-In the CHS (Cardiovascular Health Study), a longitudinal cohort study of older adults, we used relative risk regression to assess the associations of mean, variability, and trend in systolic BP, diastolic BP, and heart rate measured at 4 annual clinic visits between 2 brain MRIs with incident covert brain infarction and worsening white matter grade (using a 10-point scale to characterize leukoaraiosis). We included participants who had both brain MRIs, no stroke before the follow-up MRI, and no change in antihypertensive medication status during follow-up. Among 878 eligible participants, incident covert brain infarction occurred in 15% and worsening white matter grade in 27%. Mean systolic BP was associated with increased risk for incident covert brain infarction (relative risk per 10 mm Hg, 1.28; 95% confidence interval, 1.12-1.47), and mean diastolic BP was associated with increased risk for worsening white matter grade (relative risk per 10 mm Hg, 1.45; 95% confidence interval, 1.24-1.69). These findings persisted in secondary and sensitivity analyses. Conclusions-Elevated mean systolic BP is associated with increased risk for covert brain infarction, and elevated mean diastolic BP is associated with increased risk for worsening leukoaraiosis. These findings reinforce the importance of hypertension in the development of silent cerebrovascular diseases, but the pathophysiologic relationships to BP for each may differ. Visual Overview-An online visual overview is available for this article. 
I
n people without previous stroke, covert brain infarction (CBI) and leukoaraiosis are described as silent cerebrovascular diseases, but they have clinically important consequences. CBI is associated with a 2-to 4-fold increased risk of clinically defined ischemic stroke, independent of vascular risk factors, and a 2-to 3-fold increased risk of dementia. [1] [2] [3] [4] They may also directly disrupt functional networks, leading to deficits affecting cognition, gait, and other functions. 5 Similarly, leukoaraiosis is associated with an increased risk for ischemic stroke, worse outcomes after stroke, dementia, and mortality. [6] [7] [8] [9] [10] Leukoaraiosis prevalence in older adults exceeds 95%, and CBI is also common: the estimated prevalence of CBI in adults over age 50 is ≈20% compared with 2% to 14% for overt ischemic stroke in the United States. 2, 7 Although the American Heart Association/American Stroke Association recently published a scientific statement highlighting the importance of these conditions and the need for further studies to guide their management, optimal prevention strategies after detection of these conditions have not been established, in part because of uncertainties about their pathogenesis that may resemble or differ from ischemic stroke. 11 Furthermore, strategies for the prevention of incident CBI and worsening of leukoaraiosis have not been established. Given their high prevalence and clinical sequelae, improving the understanding of the pathogenesis of CBI and leukoaraiosis may help guide strategies for prevention of cerebrovascular diseases.
Hypertension is associated with CBI and leukoaraiosis and clinically defined ischemic stroke. 2, [12] [13] [14] Both primary and secondary stroke prevention guidelines focus on absolute reductions in systolic blood pressure (SBP) and diastolic blood pressure (DBP), but some studies suggest that very aggressive BP reductions may lead to an increased risk of recurrent stroke. Accordingly, investigators have sought to improve current understanding of the role of cardiovascular physiology in brain infarction by studying other measures, including variability in BP and heart rate (HR). Previous studies suggest associations of BP and HR variability with ischemic stroke, but these associations are inconsistent and depend on the time interval of measurement (beat to beat, daily, weekly, or visit to visit). [16] [17] [18] Despite these potential associations with ischemic stroke, it is not known if visit-to-visit BP and HR measures are associated with an increased risk of incident CBI or progression of leukoaraiosis.
In this study, we used data from 2 brain magnetic resonance imaging (MRIs) performed ≈5 years apart in the CHS (Cardiovascular Health Study) to assess associations of visitto-visit cardiovascular measurements, including mean, variability, and trend in SBP, DBP, and HR, with incident CBI and progression of leukoaraiosis, building on findings from previous work based on these scans. 19, 20 
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Study Population
As detailed in Figure 1 , 878 participants were eligible for the primary analysis and 1844 participants for the sensitivity analysis. Baseline characteristics and mean (SD) for the exposure variables in the primary and sensitivity analysis samples are presented in Table 1 (additional descriptive statistics for  each individual analysis and a comparison to all CHS participants undergoing the first MRI are provided in the Table I in the online-only Data Supplement). Among 683 participants who completed both brain MRIs and demonstrated no infarcts on the initial MRI, 101 individuals (15%) had incident CBI. Among 793 participants with white matter grade (WMG) measurements (a 10-point scale characterizing the extent of leukoaraiosis) on both MRIs and a grade of ≤8 on the initial MRI, 215 (27%) demonstrated worsening WMG. The distributions of number of CBI, WMG, and changes in WMG are shown in Figure 2 . Evaluation of the exposure variables indicated minimal correlation for most pairs and at most modest correlations for a few pairs (Table II in the online-only Data  Supplement) 
Sensitivity Analysis
An inclusive sensitivity analysis corroborated results of the primary analyses ( 
Discussion
Mean BP Is Associated With Incident CBI and Worsening Leukoaraiosis
In this prospective cohort study of older adults without previous stroke and cardiovascular disease, elevated mean SBP was associated with increased risk for incident CBI, and elevated mean DBP was associated with increased risk for worsening leukoaraiosis, extending previous findings from the CHS. 19, 20 These associations remained robust across several secondary and sensitivity analyses incorporating adjustment for vascular risk factors and antihypertensive medication status, inclusion or exclusion of participants with previous imaging-defined infarcts (in the incident CBI analyses), and classification of the outcome as dichotomous or as counts. These findings are particularly important in the setting of potentially conflicting recommendations: the Joint National Committee advises less stringent control of hypertension in elderly adults, whereas a recent scientific statement from the American Heart Association/American Stroke Association highlights the clinical relevance of imaging-defined vascular brain injury and urges, at a minimum, initiation of stroke primary prevention measures in affected individuals. 11, 21 In patients without a history of stroke, this study suggests that incident CBI and worsening leukoaraiosis could be treatment targets for control of systolic and diastolic hypertension.
Differential Associations Between Measures of Pulsatile and Steady Flow With CBI and Leukoaraiosis
Across several analyses, measures of steady blood flow (DBP and MAP) were associated with worsening leukoaraiosis. There was also a suggestion that measures of pulsatile blood flow (SBP and PP) were associated with incident CBI, although MAP was also associated with incident CBI in contrast to DBP and to a greater degree than PP. Although previous studies have reported variable associations of pulsatile and steady blood flow with different forms of imagingdefined vascular brain injury, this study provides evidence suggesting the roles of different types of hypertension in the pathogenesis of CBI and leukoaraiosis. [22] [23] [24] [25] [26] [27] The more consistent finding is the relationship of measures of steady blood flow with leukoaraiosis: multiple pathophysiologic mechanisms for the development of leukoaraiosis have been postulated, but this study emphasizes that diastolic hypertension likely has a critical role. One theory is that increased peripheral arterial stiffness (represented by increased brachial DBP as a proxy for carotid DBP) in conjunction with increased aortic pulsatility may augment transmission of the effects of aortic pulsatility to the cerebral small vessels, resulting in increased endothelial shear stress and dysfunction. 23 Alternatively, diastolic hypertension may correspond with increased peripheral arterial stiffness and reduced carotid flow velocity, resulting in reduced blood flow to cerebral small vessels and local hypoperfusion, independent of atherosclerosis. 24 By contrast, on peripheral measures of pulsatile blood flow, it is hypothesized that the late-life development of atherosclerosis in intracranial arteries may arise in conjunction with increased peripheral PP. 28 This study may support that hypothesis and may implicate atherosclerotic pathologies in the development of CBI. In light of these differential associations and the clinical significance of these conditions, future studies in the treatment of hypertension in adults (such as those in the CHS) should include incident CBI and worsening leukoaraiosis as distinct outcomes from one another and from clinically defined ischemic stroke.
HR Trend and Increased Risk for CBI
We did find an association between positive HR trend and incident CBI, although its risk estimate has a moderately wide CI and its P value did not reach significance with a conservative Bonferroni correction. This association persisted through almost all analyses, including the stratified analyses. To our knowledge, an association between visit-to-visit HR trend and cerebrovascular outcomes has not been previously described. Although mechanisms of vascular injury because of hypertension have been rigorously studied, it is less certain how changes in HR would lead to vascular brain injury. It is possible that this association may reflect a downstream or compensatory response to other changes in vascular biology that more directly lead to increased risk for CBI.
Other BP and HR Measures Are not Consistently Associated With Incident CBI or Worsening Leukoaraiosis
In this study, variability and trend of SBP and DBP and mean and variability of HR were not consistently associated with CBI or worsening WMG: some demonstrated nominal statistical significance in the most inclusive sensitivity analysis, but these findings were unstable across analyses with exclusions aimed at reducing confounding. Although HR mean and visitto-visit variability were associated with mortality in a previous CHS analysis, we did not find a consistent relationship between these measures and covert imaging-defined vascular brain injury. 29 The lack of association between SBP or DBP visit-to-visit variability and CBI is notable because it may suggest that CBI and clinically defined ischemic stroke have different relationships with BP variability.
16-18
Role of Antihypertensive Medication Use
We assessed the potential for effect modification by antihypertensive medication use by stratifying study participants into users and nonusers of a stable medication regimen. Although the interactions in the full primary analysis sample were not statistically significant, we found that the associations between our primary exposure variables and incident CBI and worsening leukoaraiosis seemed to persist in the stratum of nonusers. Interpretation of the lack of association in the stratum of medication users is less certain because of a low sample size and an absence of medication dosage and administration timing data in this study, both of which would tend to increase the variability of exposure among medication users. Future clinical trials may be useful to determine whether there is a beneficial effect of antihypertensives on imaging-defined vascular brain injury.
Strengths and Limitations
Our study has several strengths, including standardized BP and HR measurements at structured annual study visits, central adjudication of clinical events, centralized analysis of MRI scans with characterization of infarcts and WMG, and highquality data on vascular risk factors collected prospectively. In addition, this study population of healthy older adults offers an opportunity to establish these associations with relatively minimal confounding. Our study had several limitations. First, it was limited to participants who underwent 2 brain MRIs according to the CHS protocol, an exclusion that reduced our study sample size and likely introduced a selection bias. Having no MRI or only a single MRI was the most frequent reason for exclusion from this analysis, which resulted from loss to follow-up, death, and various other reasons. Previous studies of the CHS demonstrated that participants who underwent brain MRI scans were healthier than those who did not, and those who underwent both brain MRIs were healthier than those that only underwent a single scan. 19, 20, 30 Accordingly, our study may underestimate the frequency of incident CBI and worsening WMG.
Second, the sample size for the primary analyses was also limited because of the exclusions of participants with Visit-to-visit mean was calculated from 4 annual measurements. Visit-to-visit trend was calculated using linear regression (slope). Visit-to-visit variability was calculated from the SD of the residuals of the linear regression. Relative risks (RRs) and 95% confidence intervals (CIs) estimated from RR regression model adjusted for age, sex, race, clinic location, smoking status, BMI, diabetes mellitus, time between magnetic resonance imaging scans, and antihypertensive medication status. RRs are presented for mean, variability, and trend per 10 points of mm Hg for systolic blood pressure (SBP) and diastolic blood pressure (DBP) and 10 bpm of heart rate (HR). The Bonferroni corrected P value is 0.003. CBI indicates covert brain infarction; and WMG, white matter grade.
baseline coronary artery disease, congestive heart failure, and atrial fibrillation. We were concerned about the relationships between these cardiovascular conditions and our primary exposures of interest: all could be confounders or mediators of the association of these exposures on incident CBI and worsening WMG. We chose to exclude these individuals from the primary analyses and include them in a sensitivity analysis. The β coefficients and risk estimates in the sensitivity analysis did not change substantially, suggesting that these conditions may be minor confounders or mediators. Nonetheless, the main findings of this study, the associations between mean SBP and incident CBI and between mean DBP and worsening leukoaraiosis, were not affected substantially by these conditions. Third, our study focused on annual measurements and cannot detect potential associations between shorter intervals of BP and HR measurements and the outcomes.
Finally, our analysis involved multiple comparisons with potentially nonindependent exposure variables and outcomes; if these were all independent, we would expect 1 significant finding by chance alone among 18 tests of interest. Because a Bonferroni correction may inadvertently obscure meaningful associations if the exposures or outcomes are not independent, we elected to present both Visit-to-visit mean was calculated from 4 annual measurements. Visit-to-visit trend was calculated using linear regression (slope). Visit-to-visit variability was calculated from the SD of the residuals of the linear regression. Relative risks (RRs) and 95% confidence intervals (CIs) estimated from RR regression model adjusted for age, sex, race, clinic location, smoking status, BMI, diabetes mellitus, time between magnetic resonance imaging scans, and antihypertensive medication status. RRs are presented for mean, variability, and trend per 10 points of mm Hg for pulse pressure and mean arterial pressure. The Bonferroni corrected P value is 0.003. CBI indicates covert brain infarction; MAP, mean arterial pressure; PP, pulse pressure; and WMG, white matter grade. Visit-to-visit mean was calculated from 4 annual measurements. Visit-to-visit trend was calculated using linear regression (slope). Visit-tovisit variability was calculated from the SD of the residuals of the linear regression. Covert brain infarction (CBI) analysis: β coefficients and 95% confidence intervals (CIs) estimated from linear regression model adjusted for age, sex, race, clinic location, smoking status, BMI, diabetes mellitus, time between magnetic resonance imaging (MRI) scans, and antihypertensive medication status (always, never, variable). White matter grade (WMG) analysis: relative risks (RRs) and 95% confidence intervals (CIs) estimated from RR regression model adjusted for age, sex, race, clinic location, smoking status, BMI, diabetes mellitus, time between MRI scans, and antihypertensive medication status (always, never, variable). RRs are presented for mean, variability, and trend per 10 points of mm Hg for systolic blood pressure (SBP) and diastolic blood pressure (DBP) and 10 bpm of heart rate (HR). The Bonferroni corrected P value is 0.003.
uncorrected P values and a formal Bonferroni threshold for comparison.
Conclusions
In summary, this study provides evidence that systolic hypertension is associated with increased risk for CBI, and diastolic hypertension is associated with increased risk for leukoaraiosis. Combining these findings with previous studies, these differential associations could suggest differences in pathophysiologic mechanisms underlying CBI, leukoaraiosis, and clinically defined ischemic stroke. [16] [17] [18] Given the clinical significance of silent cerebrovascular diseases, these findings suggest a need to reevaluate the balance of benefits and risks of controlling systolic and diastolic hypertension in elderly adults. These findings need to be confirmed in other populations, including younger adults, and clinical trials may better establish the potential effect of antihypertensive medications on the risk of incident CBI and worsening leukoaraiosis.
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